RxDoctor Payments Data

Suzanne Bakke, PA

Physician Assistant · San Luis Obispo, CANPI 1861676553

Payments from drug & device makers

$343in general payments, 2019–2025

Across 15 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$74
  • Takeda Pharmaceuticals U.S.A., Inc.$44
  • GSK$40
  • Viiv Healthcare Company$34
  • Bayer$27
  • ARS Pharmaceuticals Operations, Inc.$23
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$343100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$343 in reported general payments places this provider in the 55th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$31,020
Medicare patients
170
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$23,746
EliquisApixaban30$21,424
RybelsusSemaglutide14$18,582
Xtampza ErOxycodone Myristate11$3,624
Levothyroxine Sodium142$2,302
Atorvastatin Calcium140$1,247
Estradiol29$1,134
Escitalopram Oxalate40$822
Albuterol Sulfate HfaAlbuterol Sulfate20$714
Losartan Potassium48$631
Bupropion XlBupropion Hcl27$626
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$611
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide16$558
Venlafaxine Hcl ErVenlafaxine Hcl17$514
Acetaminophen-CodeineAcetaminophen With Codeine11$513

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$19$42,32736 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Luis Obispo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →